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Abstract
Background: Congenital hemiplegia is the most common form of cerebral palsy (CP) accounting for 1 in 1300 live
births. These children have limitations in capacity to use the impaired upper limb and bimanual coordination deficits
which impact on daily activities and participation in home, school and community life. There are currently two diverse
intensive therapy approaches. Traditional therapy has adopted a bimanual approach (BIM training) and recently,
constraint induced movement therapy (CIMT) has emerged as a promising unimanual approach. Uncertainty remains
about the efficacy of these interventions and characteristics of best responders. This study aims to compare the efficacy
of CIMT to BIM training to improve outcomes across the ICF for school children with congenital hemiplegia.
Methods/Design: A matched pairs randomised comparison design will be used with children matched by age,
gender, side of hemiplegia and level of upper limb function. Based on power calculations a sample size of 52
children (26 matched pairs) will be recruited. Children will be randomised within pairs to receive either CIMT or
BIM training. Both interventions will use an intensive activity based day camp model, with groups receiving the
same dosage of intervention delivered in the same environment (total 60 hours over 10 days). A novel circus
theme will be used to enhance motivation. Groups will be compared at baseline, then at 3, 26 and 52 weeks
following intervention. Severity of congenital hemiplegia will be classified according to brain structure (MRI and
white matter fibre tracking), cortical excitability using Transcranial Magnetic Stimulation (TMS), functional use of the
hand in everyday tasks (Manual Ability Classification System) and Gross Motor Function Classification System
(GMFCS). Outcomes will address neurovascular changes (functional MRI, functional connectivity), and brain (re)
organisation (TMS), body structure and function (range of motion, spasticity, strength and sensation), activity
limitations (upper limb unimanual capacity and bimanual motor coordination), participation restrictions (in home,
school and recreation), environmental (barriers and facilitators to participation) and quality of life.
Discussion: This paper outlines the theoretical basis, study hypotheses and outcome measures for a matched pairs
randomised trial comparing CIMT and BIM training to improve outcomes across the ICF.
Trial Registration: ACTRN12609000912280
Background
Cerebral palsy (CP) is the leading cause of childhood
disability with an incidence of 1 in 500 live births[1].
Hemiplegia accounts for 35% (1 in 1300) of these chil-
dren and upper limb (UL) involvement is usually more
pronounced than the lower limb[2]. Management of
long-term disability and the burden of care on both the
health care system and families are substantial. Recently
the financial cost of CP was estimated at Aus$1.47 bil-
lion with Aus$124.1 million attributed to direct program
costs[3]. Families and individuals with CP accommodate
approximately 43% of these costs and the various levels
of government the remainder[3].
From an individual perspective, the impact of hemi-
plegia can be described using the International
* Correspondence: r.boyd@uq.edu.au
1Queensland Cerebral Palsy and Rehabilitation Research Centre, School of
Medicine, The University of Queensland, Brisbane, Australia
Boyd et al. BMC Neurology 2010, 10:4
http://www.biomedcentral.com/1471-2377/10/4
© 2010 Boyd et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Classification of Functioning, Disability and Health (ICF)
[4]. At the level of Body Structure and Function, chil-
dren with hemiplegia can present with changes in brain
structure and function (structural MRI, neurovascular
changes with fMRI) resulting in impairments of spasti-
city, muscle length, sensation, and weakness. Limitations
in activity performance are common in areas such as
self-care, school and household related activities. Partici-
pation can be restricted in home, school and broader
community life and may in turn impact on quality of
life (QOL). Intervention is therefore paramount to mini-
mise long term disability, and optimise functional inde-
pendence, societal participation and long term career
aspirations.
There are many models of intervention targeting defi-
cits in hand and arm function that aim to reduce activ-
ity limitations for children with congenital hemiplegia.
Historically, neurodevelopmental treatment approaches
(NDT) have been used in an attempt to ameliorate
impairments of body structure and function with the
assumption that this would transfer to gains in activity
performance[5]. However there has been little empirical
evidence to support these approaches[6,7]. Current
management of motor dysfunction includes task-
oriented, functional therapy or motor learning
approaches that collectively use repetitive practice of
functional and goal directed tasks[8-10]. The framework
of dynamic systems theory underpins some of these
contemporary approaches[11,12]. This theory purports
that spontaneous movement is generated as a product
of the interaction of many systems. These systems
include the child, the task and the environment and the
movement is generated in the most efficient manner for
a particular moment[12].
Constraint induced movement therapy (CIMT) is a
relatively new intervention derived from the basic
sciences[13]. It comprises applying a restraint to the
unimpaired UL coupled with intensive training of unim-
anual skills in the impaired hemiplegic limb. This
approach has been shown to improve UL task perfor-
mance in adults following stroke with retention of
effects at twelve months post intervention[14]. Modifica-
tion of this approach for children with CP has followed,
but until recently efficacy was limited to case reports
and small prospective studies[10,15-20]. Two small
RCTs have been performed with positive effects for
amount of use and emerging behaviours[10,21]. A
Cochrane review concluded that there was emerging evi-
dence supporting CIMT for children with hemiplegia
[22]. A further systematic review[7] that investigated all
UL interventions including CIMT, NDT and contem-
porary upper limb therapy included three RCTs of
CIMT[10,21,23]. Pooling of CIMT data for meta-analy-
sis was not possible due to small sample sizes, variation
in the type of restraint used, differing outcome measures
(many of which had no reported validity or reliability for
the population), varying intensity, and dosage of inter-
v e n t i o nm a d ec o m p a r i s o na c r o s s trials difficult[7]. Our
systematic review concluded that evidence for CIMT
should therefore be viewed cautiously and recom-
mended that further suitably powered RCTs using valid
and reliable outcome measures were required.
Conceptually, there are a number of key difficulties in
the application of CIMT to children with CP. Children
with hemiplegia, unlike adults who acquire a hemiplegia
subsequent to a stroke, have never learned to use their
UL effectively so demonstrate developmental disregard
and/or non-learned use of their impaired limb[10,16].
Consideration of developmental aspects of acquiring UL
skills and critical periods of brain development related
to UL co-ordination are therefore important. Early
bimanual use of both hands is thought to be important
for the development of the assisting hand, as the devel-
opment of motor control is modelled on effective use of
the dominant hand[24]. In healthy adults, the contralat-
eral and ipsilateral sensory motor cortex appear to act
in a co-ordinated fashion during unilateral hand move-
ments[25]. Constraint or reduced use of the dominant
hand in young children may lead to activity dependent
competitive displacement of the surviving contralateral
corticospinal projections from the affected cortex by
more active ipsilateral corticospinal projections from the
affected motor cortex, thereby compounding the pro-
blem[26]. In addition, children with hemiplegia have
bimanual coordination difficulties over and above their
unimanual deficits[27]. The relationship between unim-
anual capacity and bimanual performance is not clearly
understood and it is uncertain whether gains in uniman-
ual capacity will transfer into improvements with
bimanual performance. A discrepancy between uniman-
ual capacity and bimanual performance is often
observed in these children. When doing functional tasks
such as putting on shoes and socks, children may
adeptly use their unimpaired limb with little involve-
ment of their impaired limb. However, when directed to
do tasks with their hemiplegic limb they can demon-
strate unimanual skills that are not utilised in bimanual
tasks. Motor learning principles would suggest that
improvement in use of two hands together will be maxi-
mised by repetitive practice of bimanual goal directed
tasks[27].
Historically, therapists have focused on a bimanual
approach (BIM training) in the management of motor
dysfunction in children with hemiplegia[28]. Recently, a
publication of intensive bimanual training, Hand Arm
Bimanual Intensive Training (HABIT) was described by
C h a r l e sa n dG o r d o n [ 2 7 ] .T h i sa p p r o a c hf o c u s e do n
equal use of both hands in bimanual tasks and was
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address bimanual co-ordination while maintaining the
positive aspects of intensive training of the impaired
limb[27]. A small RCT compared HABIT (n = 10) to a
delayed treatment group (n = 10). Treatment intensity
was equivalent to that employed in CIMT trials, for 6
hours per day over a 10-day period (total 60 hours
training). A small treatment effect (h
2 of 0.256) favour-
ing HABIT was achieved on a validated bimanual
assessment the Assisting Hand Assessment (AHA)[29].
To date, CIMT and BIM training have not been directly
compared in a randomised clinical trial. A further lim-
itation of all previous studies of UL interventions has
been the lack of standardisation of intensity or environ-
mental context for the comparison or control treat-
ments[7]. These parameters will be addressed in the
present study.
The current study is funded by the National Health
and Medical Research Council (NHMRC) of Australia
(project grant 368500). The broad aim of this study is to
evaluate in a single blind randomised matched pairs
comparison trial whether a novel rehabilitation, CIMT,
is more effective than BIM training to improve UL func-
tion, societal participation and QOL in children with
congenital hemiplegia aged 5 to 16 years.
Methods/Design
A matched pairs randomised trial will be conducted
using an activity based day camp model[30] to evaluate
the efficacy of CIMT compared to BIM training in chil-
dren with congenital hemiplegia aged 5 to 16 years.
The specific hypotheses to be tested are:-
1. CIMT will reduce activity limitations and participa-
tion restrictions to a greater extent than BIM training in
children with hemiplegia.
2. CIMT will result in greater use-dependent brain
reorganisation compared to BIM training and this corti-
cal plasticity will be retained for longer periods.
3. CIMT will result in greater enhancement of partici-
pation in school and community roles.
4. CIMT will result in greater improvements in QOL.
These hypotheses will address the following specific
aims:-
1. Upper limb rehabilitation consumes a great deal of
time and is costly, and the effects may be short lived.
CIMT is a novel upper limb training where the unim-
paired arm is constrained in a “glove like splint” while
the impaired hemiplegic arm is intensively trained. This
study will determine which training approach has the
greatest impact on activity limitations and how long that
effect is retained.
2. If one approach results in greater enhancement and
retention of cortical reorganisation then this will guide
clinical practice with implications for other patients
(Traumatic Brain Injury TBI, stroke). An understanding
of the nature and timing of the brain lesion may indi-
cate which children respond better.
3. If a training program enhances community participa-
tion and improves QOL this will have a profound impact
on educational opportunities and vocational roles.
Assessments will be performed at baseline prior to the
camp and then at three weeks following completion of
the camp. Further follow-up will be performed at 26
and 52 weeks following intervention to determine reten-
tion of effects. The experimental design and outcome
measures are depicted in Figure 1.
The research ethics boards at the Royal Children’s
Hospital, Melbourne (HREC 26074 A,B,C,D), La Trobe
University (HEC 06-68), Royal Children’s Hospital, Bris-
bane (HREC 2008/018) and The University of Queens-
land (2008000961) have granted approval for the study.
Study sample and recruitment
Children and youth will be recruited from across Vic-
toria and Queensland, Australia. The Australian health
system allows all individuals access to publicly funded
services and reimbursement for private medical specia-
lists. The recruitment process will target both publicly
funded services and private practitioners with the expec-
tation that the sample will be representative of children
with congenital hemiplegia. Furthermore, financial sup-
port for families from regional areas will be made avail-
able to allow equity of access to the program and a
representative sample of children from metropolitan,
outer metropolitan and rural/regional/remote areas.
Inclusion criteria
The study will include children and youth:
1. With a confirmed diagnosis of congenital
hemiplegia.
2. Aged 5 to 16 years.
3. With predominant spasticity rather than dystonia
interfering with UL function according to the classifica-
tion of motor type by Sanger et al[31] with Modified
Ashworth Scale (MAS) grade >1 but <3[32].
4. Ability to achieve minimal active grasp with the
impaired hand.
5. Sufficient co-operation and cognitive understanding
to participate in the group activities.
For a subset of children performing the Advanced
Brain Imaging and Transcranial Magnetic Stimulation
(TMS) studies further inclusion criteria are:-
1. Sufficient co-operation to perform Advanced Brain
Imaging studies for 45 minutes.
2. No exclusions for 3 tesla Magnetic Resonance Ima-
ging (3T MRI) including no metal implants, no shunts,
no uncontrolled epilepsy as the later would be a
confound.
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tory of epilepsy.
Exclusion criteria
1. Severe muscle spasticity and/or contracture (MAS >
grade 3, i.e. muscle contracture or rigidity) which would
require spasticity management or serial casting.
2. Previous orthopaedic surgery in the UL.
3. Serial casting or Botulinum Toxin A (BoNT-A)
injections in the UL within 6 months prior to study
entry.
Sample size
According to CONSORT guidelines the primary basis
for sample size calculation is adequate power for the
comparison between the functional effects of CIMT
and BIM training at 3 weeks post intervention. Based
on data from a previous study[33], a mean difference
of 7 percentage points was proposed or 10% of the
anticipated control group mean at baseline on the
Melbourne Assessment of Unilateral Upper Limb
Function[34] as the minimum difference that is likely
to have substantial clinical importance. Our pilot data
in a study of UL training with and without intramus-
cular BoNT-A injections yielded standard deviation of
changes of 7.6 and 9.6 units in the two groups. Based
on a t-test comparison of changes using a SD of 9
units for both groups, significance (alpha) level of 0.05,
and 80% power, we require 26 participants in each
group (total sample of 52).
Figure 1 Flow chart of INCITE study according to CONSORT guidelines.
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Children will be matched in pairs according to age (12
month age bands), gender, side of hemiplegia, and level
of functional ability based on MUUL scores at screen-
ing. Once matching has been achieved and baseline
assessments completed, children will be randomised
within pairs from concealed envelopes opened by non-
study personnel. Treatment allocation will be recorded
on a piece of folded paper inside each envelope in ran-
dom order (computer generated). The randomisation
process will involve allocating a number “1” or “2’ to
each member of the pair which will be written on the
paper inside the envelope. As each pair is entered, they
will be allocated the next consecutive envelope, which
will be opened by the non-study personnel who will
read and record the treatment allocation from the paper
inside the envelope. Study personnel will be informed of
group allocation.
A matched pairs design is the design of choice as it
minimises the likelihood of group differences at baseline
that has often been present in UL rehabilitation studies
[21,29]. In order to maximise group coherence, camps
will be conducted in two age bands (two camps each of
CIMT and BIM training for children 5-10 years and one
camp each of CIMT and BIM training for children 11-
16 years).
Study treatments
Each intervention will be delivered in groups of 9 to 13
children for 6 hours per day for 2 weeks (10 days) in a
day camp model. The total dosage of intervention will
be 60 hours. After baseline assessment and randomisa-
tion children will attend either the two week BIM train-
ing camp or immediately following, a two week CIMT
camp. One week of the camp will be during school term
and one during school holidays. To optimize children’s
engagement in the intervention, day camps will be run
at a community sporting facility and will employ a cir-
cus theme with circus activities provided by professional
trainers and an additional day-excursion to an adventure
“low ropes” course. Consistent with self determination
theory[35] to maximize motivation the key elements of
competence, autonomy and relatedness will be incorpo-
rated. Competence will be achieved through scaffolding
of activities to optimise success, autonomy by allowing
choice, and relatedness through the sharing of the
experience with others of similar abilities.
Both groups will receive the same dosage and content
of intervention, delivered in the same environment. Par-
ticipants in the CIMT group will wear a tailor made
glove on their unimpaired limb while attending the day
camp, which will only be removed for toileting. Table 1
summarises the components of each intervention. The
tasks for each camp will be designed to enable either
maximal bimanual use of the hands for the designated
tasks and modified for the CIMT camp to perform the
same tasks in a unimanual approach with constraint on
the unimpaired hand.
Children will return to their regular therapy programs
at the completion of the 2-week program. Documenta-
tion of concurrent therapy programs (ongoing, addi-
tional therapy or interventions, change in spasticity,
medications or lower limb interventions) will be
recorded at each follow up assessment as these would
not be able to be controlled over a 12 month period.
Therapy protocols and delivery
Three occupational therapists (LS,RG,KP) and one
physiotherapist (RB) will plan and lead all intervention
groups. The core therapists will be responsible for
daily grading of activities and modification of tasks for
the participants in each group as required. Planning
activities for each group will require task analysis, and
guidelines for grading to challenge children with vary-
ing capabilities. It is expected that many activities pre-
pared for the BIM training group (focusing on
bimanual tasks) will need to be modified for the CIMT
group (focusing on unimanual tasks). An example of
an activity analysis and grading for groups is provided
in Additional file 1, Table S2. Volunteer occupational
therapists, physiotherapists, human movement scien-
tists, therapy students and sports recreation staff
(YMCA) will assist with program delivery with a ratio
of 2 participants to one staff member. Prior to com-
mencement of the daily program, staff will be briefed
and given specific tasks with written instructions out-
lining how each activity will be performed for the spe-
cific children they are supervising. Task content record
sheets will be completed each day, summarising each
activity for every child, including time taken, number
of repetitions and how well the children performed the
activity and their level of engagement. Video footage of
each session will be taken for further independent con-
tent analysis. A debriefing session for the entire group
with an independent staff member and separately for
the staff will be conducted at the conclusion of each
day.
Professional circus trainers will lead the two hour cir-
cus workshops and a YMCA leader and/or Human
Movement scientist will run the gross motor games ses-
sion. The core therapy team will meet with the circus
trainers and gross motor program leader to design these
programs and at the end of each session to discuss and
modify the program as required and provide guidance
to grading of tasks for participants. The core therapy
team will also meet daily to review individual partici-
pants’ goals and continually grade their program. A
daily record of attendance will be kept.
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A number of classification measurements will be used to
describe the sample at the level of brain structure, brain
reorganisation, manual abilities, severity of impairment
(body structure) and gross motor function. This study
will be the first to our knowledge to comprehensively
measure and compare the impact of two models of UL
intervention across all domains of the ICF[4].
1. Classification of the sample
The participants entered into the study that meet the
inclusion criteria will be classified according to:
a) Manual Abilities Classification System (MACS)
The MACS classifies the child’s ability to handle objects
in daily activities on one of 5 levels[36]. The MACs has
reported construct validity, and excellent inter-rater
reliability (ICC 0.97 between therapists and 0.96
between therapists and parents)[36]. It is expected that
all children in the sample will be MACS level I (able to
handle objects easily and successfully) or level II (able to
handle most objects but with somewhat reduced quality
and/or speed of achievement so that alternate ways of
performance might be used).
b) Gross Motor Function Classification System
(GMFCS)
The GMFCS classifies the child’s ability to carry out self
initiated movements related to sitting and walking across
5 levels[37]. The GMFCS has strong construct validity
with the Gross Motor Function Measure (r = 0.91)[38]
and good inter observer reliability between professionals
and between professionals and parents[39,40]. In this sam-
ple of children with congenital hemiplegia it is expected
that most children will be GMFCS level I or II.
Table 1 Summary of intervention content
Session (and Activities) Allocated
Time
CIMT: Type of involved hand use BIM training: Type of involved hand use
Fine motor activity
stations
a) Games 1 hour Reach, precision grasp, power grasp, tool use,
controlled placement and release, finger isolation, in-
hand manipulation, wrist extension, supination
Stabilisation, symmetric and asymmetric bilateral
movements, precision grasp, controlled placement
and release, finger isolation, in-hand manipulation,
wrist extension, supination
b) Functional tasks
c) Cooking
d) Art and crafts
Circus Workshop
a) Warm up and stretch 2 hours Active stretching whole body Active stretching whole body
b) Ribbons Grasp, shoulder external and internal rotation,
adduction, horizontal abduction, flexion, elbow and
wrist extension, supination
Grasp, shoulder external rotation, adduction,
horizontal abduction, elbow and wrist extension.
Symmetric movements.
c) Devil Sticks Grasp, shoulder adduction and flexion, elbow and
wrist extension
Grasp, symmetric shoulder flexion, elbow
extension, wrist extension. Asymmetric shoulder
adduction.
d) Hoops Grasp, shoulder adduction and flexion, elbow
extension, supination and wrist extension.
Grasp, shoulder adduction and flexion, elbow and
wrist extension. Asymmetric movements
e) Spinning plates Grasp, shoulder adduction and flexion, elbow
extension, supination and wrist extension, finger
isolation, asymmetric bilateral movement
f) Acrobalance Strength, dynamic and static balance Strength, dynamic and static balance
g) Aerials Power grasp, upper body strength. Power grasp, upper body strength & symmetry.
Mealtimes
a) Preparation 1.5 hours Grasp and transportation, precision grasp, tool use,
elbow flexion, extension, supination, wrist extension,
radial deviation
Stabilisation, grasp, tool use (knife and fork),
asymmetric bilateral movements
b) Eating
c) Cleanup
Games
a) Parachute Grasp, shoulder flexion, extension, adduction, elbow
and wrist extension, supination, throw and catch
Symmetric and asymmetric movements,
stabilisation, grasp, shoulder flexion, extension,
adduction, elbow and wrist extension, supination
b) Sports
Debriefing 0.5 hour Group discussion about day Group discussion about day
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The Zancolli Scale[41] classifies severity of forearm
alignment by measuring the contribution of spasticity
and muscle length in the wrist and finger flexors in
active wrist and finger extension. The Zancolli scale was
developed to classify impairment and alignment of the
hemiplegic hand before and after surgery. Three levels
range from I (minimal flexion spasticity, complete
extension of fingers with wrist in neutral position or less
than twenty degrees of flexion) to III (severe flexion
spasticity, no extension of fingers even with maximal
wrist flexion). It is expected that participants will have
either a level I or II Zancolli score.
d) House Functional Classification Scale
The House Functional Classification Scale[42] was ori-
ginally developed to evaluate hand function following
surgery. It consists of nine grades ranging from 0 (does
not use) to 8 (full spontaneous use). The House scale
will be used to rate functional use of the impaired UL.
Both the Zancolli Scale and House Functional Classifica-
tion Scale have been found useful in describing hand
function in a population based survey of children with
CP[43].
2. Primary and Secondary Outcome Measures
The primary outcome measure of interest is UL activity
performance for unimanual capacity using the Mel-
bourne Unilateral Upper Limb Assessment at 26 weeks
follow up. Secondary measures include measures across
all domains of the International Classification of Func-
tioning, Disability and Health (ICF).
Measures of body structure will include both the posi-
tive features of the upper motor neurone syndrome
(muscle spasticity, length) and the negative features
(weakness, dexterity and sensation). Positive features
will be assessed in the impaired (hemiplegic UL) while
negative features will be compared between limbs (to
account for any unintended effects of wearing the con-
straint on the unimpaired hand in the CIMT group).
Measures of activity will assess unimanual capacity in
the impaired limb (using the MUUL), bimanual perfor-
mance between the upper limbs (using the Assisting
Hand Assessment) and the achievement of individua-
lised outcomes (with the Canadian Occupational Perfor-
mance Measure). Participation will be assessed at home,
in school and community life using both child and par-
ent proxy response. Environmental barriers and facilita-
tors to participation will be evaluated. In addition to
these measures, the broad domains of quality of life will
be assessed.
3. Neurovascular measures
a) Whole-brain functional MRI studies
We have previously used functional Magnetic Resonance
Imaging (fMRI) to localise the motor cortex in patients
with tumours and dysplastic lesions[44], to monitor the
sensory cortex in patients recovering from stroke[45,46]
and to examine functional reorganisation in cerebral
palsy[46,47] and have combined this with TMS to loca-
lise the motor cortex in stroke patients[48]. We now
plan to use similar techniques to investigate brain reor-
ganisation in response to therapy in children with CP.
Brain reorganisation has been demonstrated using TMS
and fMRI following intensive UL training in adults after
chronic stroke[49]. Functional MRI or blood oxygen
level dependent (BOLD) contrast is a robust and non-
invasive method of detection of regional tissue changes
in venous oxygenation in response to task related activa-
tion[50].
Functional MRI has provided new information in
understanding real time cerebral blood flow changes in
response to behavioural activation[51]. Recent fMRI stu-
dies have shown that individuals with chronic stroke
can be trained to improve finger control with intensive
practice and this can be accompanied by increases in
motor cortex activation[49]. It has been suggested that
intensive arm training may result in rapid brain reorga-
nisation[52]. Our group has undertaken the first study
of serial fMRI in young children with CP to determine
central neurovascular responses to treatment[33]. We
have achieved 90% compliance with serial fMRI and
good reproducibility of the location of activation for the
unimpaired limb for two motor tasks in children with
hemiplegia. There are a very limited number of motor
studies with fMRI in children with CP and no serial
fMRI motor studies measuring outcome associated with
intense models of UL training.
Functional imaging at 3 tesla on a Siemens MAGNE-
TOM Trio MR scanner will be conducted at the Brain
Research Institute, Melbourne. This research dedicated
3T scanner provides approximately twice the signal to
noise ratio for functional imaging compared to conven-
tional 1.5 tesla scanners. We take advantage of this to
reduce the time in the scanner for children and improve
the resolution of data collected. To prepare for the real
fMRI scan all children will practice in a mock MRI
scanner using techniques that have achieved 90% com-
pliance in our earlier studies. During scanning of their
anatomical images the children will be able to watch a
favourite video. Children will lie supine, with their head
immobilised with one immobilisation pad to minimise
head movement. In the scanner, children will perform
two motor tasks, active and passive wrist extension at 2
Hz. These tasks are frequently impaired in children with
hemiplegia and most likely to show a response to train-
ing. Individual forearm resting splints will standardise
the starting positions. The motor paradigm will consist
of a 2-condition block design, visually cued via instruc-
tions projected on a screen. The baseline condition is
no movement. A tape recording of a metronome at 2
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ment. Verbal cues to commence and end the task will
be given. The task and rest periods are 30 seconds with
the activation cycle repeated four times. An additional
five minutes of resting-state fMRI will also be collected
for analysis of functional connectivity. Tasks performed
prior to resting-state fMRI can influence functional con-
nectivity[53], so the resting-state data will be collected
after the motor paradigms have been completed to pro-
vide some consistency in this regard. The whole assess-
ment will take no longer than 45 minutes. The actual
movements performed in the scanner will be rated for
speed, the range of motion actually performed, ability to
isolate the movement and presence of mirror move-
ments in the contralateral hand or general body move-
ments. If there is evidence of task-correlated breath-
holding[54], the task will be repeated.
Functional MRI will be acquired using a BOLD acquisi-
tion sequence (Gradient-recalled-echo (GRE) echo-planar
imaging (EPI), Repetition Time (TR) = 3.0 s, Echo Time
(TE) = 30 ms, Flip angle = 85°, Slice thickness = 3 mm,
FOV = 216 mm, 44 slices, 72 × 72 matrix yielding an in-
plane resolution of 3.0 mm × 3.0 mm). A single set of
T2-weighted anatomical, FLAIR and 3D T1 volumes will
also be collected. Functional MRI image processing, ana-
lysis and visualisation will be performed using iBrain(tm)
software[46] and SPM software (Wellcome Department
of Imaging Neuroscience, London, UK).
Pre-processing of the fMRI images will include slice-
timing correction using a temporal interpolation scheme
to estimate the response at the time of commencement
of each acquisition volume, motion correction (realign-
ment) within session and nonlinear registration across
sessions for each participant, and spatial normalisation
to the standard Montreal Neurological Institute (MNI)
template supplied with SPM. In the realignment step,
images within a session will be aligned to a single target
image within that time series to minimise the effects of
participant motion between scans. The target selected
by iBrain(tm) is the image whose within-brain centre-of-
mass is located closest to the median of all images in
that time series. Target images from each session of a
subject will then be non-linearly spatially normalised to
as u b j e c t - s p e c i f i cs p a c ei na ni t e r a t i v ef a s h i o nt oe n s u r e
unbiased registration of images across sessions; this step
is designed to correct, as far as practicable, non-linear
image distortions that may differ from session to ses-
sion. The step will be undertaken within subject rather
than directly to the standard template to maximise the
fidelity of within-subject registration. The mean of the
within subject registered images will then be spatially
normalised to the standard MNI template. Because
many participants have large lesions, spatial normalisa-
tion to the MNI template will be undertaken using only
an affine transform. In practice, the image transforma-
tions derived in each step described above will first be
combined and then applied in one step to minimise
resampling artefact when writing the final images. The
spatially normalised image data will be smoothed with
an isotropic Gaussian kernel at least twice the voxel size
to fulfil the assumptions of Gaussian random field the-
ory (RFT).
Using the general linear model (GLM), statistical para-
metric maps will be computed for each session of each
subject. Temporal autocorrelation will be modelled
using a white noise and autoregressive AR(1) model
within SPM. Motion correction parameters will be
included as covariates of no interest. Details regarding
the specific implementation of the GLM and RFT by
SPM are available elsewhere[55]. Due to the heterogene-
ity in lesion location and size across participants, group
analysis of intra-participant change in activation will be
undertaken using a region of interest approach with the
assistance of iBrain(tm) software.
b) Diffusion Imaging Acquisition and White Matter
Fibre Tracking
Participants will be scanned using a 3T Seimens MAG-
NETOM Trio whole body MRI scanner located at the
Brain Research Institute, Melbourne. In addition to a
number of standard radiological scans (T1, T2, FLAIR
and 1 mm isotropic MPRAGE structural scan), diffu-
sion-weighted images suitable for tractography studies
will be acquired using a fully optimised single-shot,
spin-echo echo-planar diffusion sequence. The imaging
parameters will be (54 axial slices, TR/TE 7200/110 ms,
2.3 mm isotropic resolution, acquisition matrix: 104 ×
104, parallel imaging reduction factor of 2, 60 diffusion
encoding directions with a b value of 3000 s mm
-2). The
total imaging time for this sequence is 9 minutes. Diffu-
sion-weighted MR white-matter tractography will be
undertaken in a manner robust to crossing fibres, using
constrained spherical deconvolution (CSD) and prob-
abilistic streamlines[56-58] using MRtrix software (Brain
Research Institute, Melbourne Australia; http://www.
brain.org.au/software).
c) Brain Reorganisation
Transcranial Magnetic Stimulation (TMS) will be per-
formed on all participants in both groups at baseline
then at 3 and 26 weeks post intervention. TMS will be
delivered to both hemispheres. For each participant,
care will be taken to perform both studies at approxi-
mately the same time of day so as to increase the
repeatability of the measurements.
During TMS, participants will sit in a comfortable,
reclining chair. Surface electromyographic (EMG)
recording will be made from the abductor pollicis brevis
muscle (APB) using disc electrodes in a tendon-belly
arrangement. The motor evoked potentials (MEPs) will
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graphy machine. Band-pass filtering (10 - 5000 Hz) was
used. Sweep speed for threshold determination will be
100 ms and the gain will be set to 100 μV/div. Auditory
EMG feedback will be given to ensure complete, volun-
tary relaxation of the target muscles.
The experimental session will record the following
parameters:
i) Motor Threshold (MT)
Stimulation will commence at 30% of maximum output
and increase in 5% increments until the motor evoked
potential (MEP) is established. 1% changes in intensity
will then used to calculate the threshold value. Motor
threshold is defined as the lowest level of stimulus
intensity which produced a MEP in the target muscle of
peak-to-peak amplitude > 100 μV on 50% or more of 10
trials[59].
(ii) MEP Recruitment Curves
The maximum compound muscle action potential
(CMAP) amplitude of the resting APB will be deter-
mined by supramaximal stimulation of the median
nerve at the wrist. For each participant, the average of
the CMAP amplitudes obtained after three stimuli will
be calculated as was defined as 100%[60]. MEPs
obtained by Single pulse TMS using different rando-
mized stimulus intensities of 110, 120, 130, and 140%
MT will be expressed as a percentage of the CMAP in
order to obtain recruitment curves[61]. An average of
10 peak-to-peak MEPs recorded for each stimulus inten-
sity will be calculated.
For motor thresholds and recruitment curve measure-
ments, the stimulus will be delivered to the contralateral
cerebral hemisphere using the appropriate direction of
coil current flow (anticlockwise for left cortical stimula-
tion and clockwise for right cortical stimulation). This
will be performed using a flat circular 9 cm diameter
magnetic coil (14 cm external diameter) connected to a
Magstim stimulator (Magstim, Whitland, Dyfed, United
Kingdom). The centre of the coil will be positioned over
the vertex and held in a plane tangential to it. The coil
will be held in place by a support stand, and its position
will be checked regularly through each experiment.
(iii) Ipsilateral Motor Pathways
This will be performed using a figure-of-eight-shaped
coil (outer diameter of each loop 70 mm) connected to
a Magstim stimulator (Magstim, Whitland, Dyfed, Uni-
ted Kingdom). The coil will be placed tangentially over
the ipsilateral hand motor cortex with the handle point-
ing back and laterally 45° away from the midline at the
optimal site for the activation of the APB. This is
thought to be the best position for activating the pyra-
midal cells trans-synaptically and preferentially elicits
late I-waves[62]. The direction of current induced in the
brain will be anterior to posterior.
4. Body functions and structures
T h ep o s i t i v ef e a t u r e so ft h eU M Ns y n d r o m ew i l lb e
measured to grade the impact of intervention on the
positive impairments and to compare severity between
the groups after random allocation. Active and passive
range of motion will be assessed primarily for the
impaired shoulder, elbow, forearm (pronator teres),
wrist flexors (flexor carpi ulnaris, flexor carpi radialis),
fingers and thumb adductors (adductor pollicis) using
goniometry[33]. Spasticity will be measured using the
Modified Tardieu Scale[63] at fast velocity in the fore-
arm agonists and the MAS[32,64] in the same muscle
groups.
The negative features of the UMN syndrome will be
measured to describe the sample and grade the effects
of intervention. Each test will be performed in both the
impaired (hemiplegic limb) and unimpaired (hand writ-
ing) UL to compare sensory function between limbs and
evaluate the effects of treatment on both limbs. Two
aspects of sensory impairment will be measured.
(i) Stereognosis will be assessed on the impaired and
unimpaired limbs using the approach originally
described by Feys[65]. Three familiar objects (teaspoon,
key, peg) and six similar matched objects (safety pin and
paperclip; pen and pencil; coin and button) will be used.
With vision occluded, children will be presented with
each item. A corresponding set of items will be used to
allow children to identify the object in order to mini-
mise any errors due to incorrect naming of the object.
(ii) Moving two point discrimination (M2PD) will be
measured using the Disk-criminator® (Baltimore, Mary-
land) on both the impaired and unimpaired limbs.
Either one or two points will be randomly applied in
continuous moving firm contact longitudinally to the
pulp of the index finger with vision occluded[66]. The
minimum distance participants can usually distinguish
between two discrete points, ranging from 2 mm (nor-
mal) to 15 mm (poor) were recorded[67].
(iii) Grip strength will be measured using a hand held
dynamometer (Smedley, Takei Scientific Instruments Co
Ltd). Grip strength will be measured for three attempts
on the impaired and unimpaired limbs (kilograms force,
Kgf) according to the guidelines of the American Society
of Hand Therapists[68]. The mean of the three attempts
will be used to compare limbs and to evaluate changes
over time.
5. Activity Outcomes
a) Unimanual capacity
(i) Melbourne Unilateral Upper Limb Assessment of
Function (MUUL)
The MUUL[34] measures aspects of upper limb impair-
ment and quality of upper limb function and will be the
primary outcome measure. It consists of sixteen criter-
ion-referenced items examining aspects of reach, grasp,
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criteria with maximum possible raw score of 122. Raw
scores are computed into percentage scores. The MUUL
test has very high internal consistency (a =0 . 9 6 ) [ 6 9 ] .
Inter-rater and intra-rater reliability is very high for
total test scores (ICC 0.95 and 0.97 respectively) and
moderate to high for individual items (ICC 0.69 - 0.91).
Test-retest reliability is moderate to high for items and
high for total test scores[69]. The MUUL has established
construct and content validity during test development
[34]. Comparison of the MUUL and components of the
Pediatric Evaluation of Disability Inventory (PEDI)
yielded high correlation coefficients, further supporting
construct validity[70]. Previous results of a reliability
s t u d yf o u n dac h a n g eo f1 2 %f o ri n t r a - r a t e rr e l i a b i l i t y
and 14% for inter-rater reliability was required to sug-
gest a clinically significant effect[34]. In a subsequent
study investigating the interrater reliability and measure-
ment error of the MUUL in a group of children with
hemiplegia aged 5 to 8 years, results yielded a standard
error of measurement (SEM) of 2.6% with the smallest
detectable difference (SDD) of 8.9%[71]. A further inves-
tigation of interrater reliability and SEM of trained and
untrained raters yielded SEM of 2.56 and 3.37 respec-
tively[72]. Together these studies suggest that the SDD
may be smaller than that originally published by Randall
et al. However, reliability studies differ in terms of the
study population in relation to age and type of CP, mak-
ing it difficult to generalise results to our study popula-
tion assessed by one trained rater masked to group
allocation. Establishment of intra-rater reliability for this
study is therefore required to determine the SDD and
define children who achieve a significant clinical
response.
(ii) Jebsen Taylor Test of Hand Function (JTTHF)
The JTTHF measures unilateral speed and dexterity on
timed tasks[73]. The test measures speed and accuracy
of performance on various complexities of grasp and
release tasks using everyday items. The original test
designed and validated in adults and typically developing
children will be modified with omission of the writing
activity and by reducing the maximum allowable time of
each task to 2 minutes to both reduce frustration and
allow comparison with similar studies in children with
congenital hemiplegia[21,29,74]. The JTTHF has been
s h o w nt ob er e s p o n s i v et oc h a n g ed u et oa ni n t e r v e n -
tion, however there are difficulties with stability of test-
retest performance in the unimpaired limb[21,29,30,74].
(b) Bimanual performance
Assisting Hand Assessment (AHA)
Bimanual performance will be assessed using the AHA.
This is a Rasch analysed measure of the effectiveness
with which a child with a unilateral impairment makes
use of his/her impaired hand in bimanual tasks[75]. The
test consists of twenty-two items that are videotaped
and each scored on a four point rating scale, yielding a
range of scores between 22 and 88. Scaled scores are
calculated by transforming the total raw score to a per-
centage and range from 25 to 100. Rasch analysis allows
conversion of these ordinal scores into logits (log odds
probability units) which are equal interval measures.
Inter-rater reliability is high for summed scores (ICC
0.98) as is intra-rater reliability (ICC 0.99). There are
three versions of the AHA; small kids, school kids and
an adolescent version. Test-retest reliability is high for
small kids (ICC 0.99) and school kids (ICC 0.98) and
reliability between the two forms (small kids versus
school kids) is also high (ICC 0.99). The AHA has been
shown to be responsive to change due to an UL inter-
vention[29,30]. Investigation of reliability yielded a SDD
of 3.89 raw scores for the small kids and 3.65 raw scores
for the school kids version[76]. The AHA requires stan-
dardised training and certification of raters[75]. The
AHA will be scored by one certified rater whom will be
masked to group allocation and order of assessment.
(c) Individualised outcomes
Canadian Occupational Performance Measure (COPM)
The COPM[77] is a standardised individualised, client
centred measure that evaluates client’s self perception of
occupational performance over time. Client’si d e n t i f y
areas of difficulty in everyday occupational performance
and rate their performance and satisfaction for each
problem on a scale from 1 to 10. An average score for
performance and satisfaction is calculated. The COPM
was designed for all ages and disability groups. There is
good evidence of construct, content and criterion valid-
ity[78-80]. The retest reliability of the performance and
satisfaction scores on the COPM is high (ICC 0.76-0.89)
[81,82]. The COPM has demonstrated responsiveness to
change in paediatric clinical trials[83,84]. A 2 point
change on COPM performance has been reported as
being clinically significant[77] In the present study the
COPM will form the basis of goal setting for therapy.
T h eC O P Mw i l lb ea d m i n i s t e r e db yo n eo ft h es t u d y
occupational therapists with the child/adolescent and
where necessary with parental input.
6. Participation Outcomes
Three assessments were chosen to capture participation
restrictions across home, school and community life
based on a systematic review of participation measures
for children with hemiplegia[85].
a) Assessment of Life Habits (LIFE-H for children ver-
sion 1.0)
The LIFE-H is designed for children aged 5 to 13 years
and measures life habits in home, school and neighbour-
hood environments[86,87]. It is a questionnaire com-
pleted by the parent/caregiver about the child. The child
form is based on an adult version[86]. The long form
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includes regular activities (eating meals, communication,
and mobility) and social roles. A weighted score ranging
from 0 to 10 is generated for each category and overall
total. Evidence of construct validity was established dur-
ing test development[87] and criterion validity with
strong correlations between the LIFE-H and PEDI and
Functional Independence Measure for Children (Wee-
FIM)[88]. Adequate to excellent internal consistency (a
0.73 - 0.90 for categories, 0.97 for daily activities and 0.90
for social roles), intra-rater (ICC 0.83 - 0.95 for daily
activities), inter-rater (ICC 0.8 - 0.91 for daily activities
and 0.63 - 0.9 for social roles) and test-retest reliability
(ICC 0.73 for total score) have been established[89]. Four
categories will be evaluated in this study including nutri-
tion (eg. mealtime activities), personal care (eg. dressing),
education and recreation. These areas were considered to
reflect many of the identified difficulties confronted by
children with congenital hemiplegia that might be amen-
able to the intervention program.
(b) Children’s Assessment of Participation and Enjoy-
ment (CAPE)
The CAPE was designed to measure childrens participa-
tion in formal and informal leisure and recreation activ-
ities outside of school[90]. It evaluates five aspects of
participation, including diversity (number of activities
participated in), intensity (frequency of participation),
with whom, where (the environment) and the level of
enjoyment. Scores can be generated for formal and
informal domains and five activity types. Total test
diversity scores can range from 0 to 55 and intensity
scores from 1 to 7. These are the two areas of interest
in this study. Content and construct validity were estab-
lished during test development[90] and in a subsequent
validation study[91]. Test-retest reliability is adequate
for diversity (ICC 0.67-0.77) and intensity (0.72-0.81)
and high for inter-rater reliability (0.82-0.99)[90]. The
interview method of administration will be used, with
the expectation of establishing rapport with the children
in the study.
(c) School Function Assessment (SFA)
The SFA evaluates a child’s performance in a range of
functional tasks that are necessary for participation in
academic and social activities in primary school[92]. The
first section of the assessment specifically measures par-
ticipation in six school activity settings (general or spe-
cial education classroom, playground, transportation to
and from school, bathroom, transitions to and from the
classroom and mealtimes). The remaining two sections
measure activity performance and task supports. All
three sections can be administered independent of each
other,[92] so in order to reduce burden, only the partici-
pation domain will be used. The SFA has established
validity using expert panels and factor analysis[92,93].
The SFA has high internal consistency (Cronbachs alpha
(a) 0.92 - 0.98 for scales), excellent test-retest reliability
(ICC 0.80 - 0.99) and adequate interrater reliability (ICC
0.70 for participation)[92,94]. The participation section
will be completed by the child’s teacher during a tele-
phone interview.
7. Environmental Measures
(a) The Craig Hospital Environmental Factors (CHIEF)
This is a generic measure that evaluates the impact of
attitude and support barriers, services and assistance
barriers, physical and structural barriers, policy barrier,
and work and school barriers to participation. It has
excellent established reliability with high test-retest (ICC
0.93 for total score) and internal consistency (a =0 . 9 3 )
and good content and discriminant validity[95].
(b) The Study Questionnaire
A study questionnaire was developed to capture demo-
graphic information that has been shown in the litera-
ture to influence a child’s participation. These include
family ethnicity, socio-economic status, family structure
and supports, and family interests. A measure of social
advantage/disadvantage will be derived from postcode of
residence using the Index of Relative Socio-economic
Advantage/disadvantage (2006) from the Australian
Bureau of Statistics[96]. Deciles will be reported on a
continuum with lower scores reflecting greater socio-
economic disadvantage and higher scores reflecting
socio-economic advantage.
8. Quality of Life
(a) The Cerebral Palsy Quality of Life Questionnaire for
Children (CPQOL-Child)
The CPQOL-Child[97] will be used to capture parental
report of their child’s perceptions of quality of life
(CPQOL Primary Caregiver Questionnaire). For children
and youth of nine years or older, the CPQOL Child
R e p o r tQ u e s t i o n n a i r ew i l la l s ob eu s e dt om e a s u r ec h i l -
dren’s own perceptions of their quality of life. Results of
factor analysis demonstrated that the CPQOL-Child
measures 7 broad domains of quality of life: social well-
being and acceptance, functioning, participation and phy-
sical health, emotional wellbeing, access to services, pain
and impact of disability and family health. The internal
consistency ranges from 0.74-0.92 and 2 week test re-test
reliability ranges from 0.76-0.89. As expected, the
domains moderately correlated with the CHQ, KIDSC-
REEN, and GMFCS. The CPQOL-Child is designed to be
used to evaluate the effectivness of interventions for chil-
dren with cerebral palsy and to gain further understand-
ing about the determinants of QOL. The CPQOL-teen
version for youth 14-18 years was not available at the
commencement of the present study so that the child
version was used for the entire sample. A recent publica-
tion has confirmed that the domains for the Teen version
are very similair to the Child version[98].
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In addition to the condition specific QOL tool, the
CPQOL-child, a generic measure will be used to com-
pare parents report of QOL for children with CP com-
pared to their age, gender and environmentally
matched peers (the buddies). The Kidscreen has been
described as the most useful generic measure of QOL
of children as it addressed the multidimensional con-
struct of QOL through various domains and focused
specifically on the well-being of children, as the
defined by the WHO definition of QOL[99]. It was
developed to implement the views of children, through
focus group work of 3000 children[100]. The question-
naire takes only 15-20 minutes to complete. The
KIDSCREEN-52 Questionnaire consists of 52 questions
across 10 domains. These domains include 1) Physical
Well-being, 2) Psychological Well-being, 3) Moods and
Emotions, 4) Self-Perception, 5) Autonomy, 6) Parent
Relations and Home Life, 7) Social Support and Peers,
8) School Environment, 9) Social Acceptance (Bully-
ing), 10) Financial Resources. A child self report was
administered for children 8-18 years old and a parent
proxy version was administered for parents of children
5-18 years. Children below the age of 8 were unable to
s e l f - r e p o r ta st h e i rr e p o r t sw e r el i k e l yt ob eu n r e l i a b l e .
Reliability was calculated by Chronbach’sA l p h a sa n d
ranged between 0.76 and 0.89 throughout the 10
domains of HRQOL. Convergent and discriminant
validity were tested using information of child’sp h y s i -
cal and mental health. Correlations of up to 0.55 were
found when correlating the KIDSCREEN-52 dimen-
sions with frequency of physical complaints[100].
Comparison to Typically developing children
Fifty-two typically developing peers ("buddies”) matched
with the study participants according to age, gender and
classroom that they attend will be invited to participate.
Typically developing children in this ‘bring a buddy” sys-
tem will be assessed at baseline, 26 and 52 weeks to
provide a reference for participation in home, school
and community life and QOL. At study entry the typi-
cally developing age and gender matched controls “the
Buddies” will meet the following criteria:
Inclusion Criteria
1. Typical development with no history of upper limb
dysfunction, developmental or learning disability.
Exclusion Criteria
1. Diagnosis of learning disability, developmental disabil-
ity, history of behavioural problems, visual or hearing
difficulties that would impact on function and
participation.
2. History of congenital or acquired upper limb
dysfunction.
The procedure for recruiting the “buddies” is that they
will be identified by the study participants and their
families, and will be in the same class at school and be
invited to participate by the child with hemiplegia in the
study. Once “buddy” participants agree to be contacted
by the researchers they will be sent an information
statement and consent form, followed by telephone con-
tact to arrange time for an initial assessment. At the
initial assessment the study and assessment procedure
will be explained and the “buddy” will be screened. Each
buddy will be assessed on the CAPE, LIFE-H, and
Kidscreen to provide comparison data for the study
sample. Only children attending regular school will be
invited to participate to provide an age, gender and
environmentally matched reference sample.
Analyses
All assessment forms will be developed using scannable
Teleforms (Teleform, 2005). Forms will be entered,
scanned and visually checked by staff trained in use of
the software. Data will be transferred electronically into
Microsoft Access 1997. Analyses will be on an inten-
tion-to-treat basis using STATA 10. Data from each
outcome measure will be summarised for each treat-
ment group and descriptive statistics (frequencies,
means, medians, 95% confidence intervals) calculated
dependent on data distribution. We anticipate that
groups will be similar on baseline measures due to the
matched pairs design. Initially between group differences
will be evaluated at the three follow-up assessment
points using independent t-tests or Wilcoxon rank sum
test. Within group changes between baseline and the
follow-up assessments for continuous variables will be
evaluated using paired t-tests or Wilcoxon matched-
pairs sign rank test. A significance level of 0.05 will be
used.
For the TMS data Student’sp a i r e dt - t e s tw i l lb eu s e d
for analysis of the difference between pre and each post
intervention (3 and 26 weeks) mean MT and MEP
ratios. This will be performed in each group for the
impaired side and the unimpaired side.
To determine the intra-rater reliability of our trained
occupational therapist rater on the MUUL, intraclass
correlation coefficients will be calculated (3.1) with 95%
confidence intervals from total MUUL percentage scores
[101]. The standard error of measurement (SEM = SD ×
√(1-ICC)) and the smallest detectible difference (SDD =
SEM × 1.96 × √2) will be calculated[102].
Post hoc analyses will be undertaken to investigate
clinical characteristics of children who have a greater
response to either intervention.
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This paper presents the background and design for a
matched pairs randomised trial comparing CIMT and
BIM training for children with congenital hemiplegia.
T h i ss t u d yi st h ef i r s tt od i r e c t l yc o m p a r et h et w o
approaches and will be the largest study of either
approach to date. Furthermore, we will be evaluating
the outcomes of the intervention program across all
domains of the ICF using valid and reliable measure-
ment tools. It is anticipated that the results of this study
will be disseminated widely through peer reviewed jour-
nals and international academic conferences.
Additional file 1: Examples of planning and modifications to fine
motor activities for the Constraint Induced Movement Therapy
(CIMT) and Bimanual training (BIMAN) groups.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2377-10-4-
S1.PDF]
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